BridgeBio Pharma Return on Investment 2018-2024 | BBIO

Current and historical return on investment (ROI) values for BridgeBio Pharma (BBIO) over the last 10 years.
BridgeBio Pharma ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-06-30 $-0.51B $0.64B -91.87%
2024-03-31 $-0.48B $0.68B -98.26%
2023-12-31 $-0.61B $0.38B -136.48%
2023-09-30 $-0.56B $0.53B -120.28%
2023-06-30 $-0.53B $0.37B -111.34%
2023-03-31 $-0.46B $0.50B -83.79%
2022-12-31 $-0.51B $0.46B -85.98%
2022-09-30 $-0.55B $0.57B -79.71%
2022-06-30 $-0.57B $0.68B -80.71%
2022-03-31 $-0.58B $0.67B -76.31%
2021-12-31 $-0.58B $0.84B -68.67%
2021-09-30 $-0.54B $0.64B -69.29%
2021-06-30 $-0.51B $0.92B -64.47%
2021-03-31 $-0.54B $0.97B -71.19%
2020-12-31 $-0.47B $0.58B -63.80%
2020-09-30 $-0.43B $0.69B -57.65%
2020-06-30 $-0.36B $0.79B -50.40%
2020-03-31 $-0.31B $0.91B -58.85%
2019-12-31 $-0.27B $0.57B -91.83%
2019-06-30 $-0.17B inf%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $4.791B $0.009B
BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
Bausch Health Cos (BHC) Canada $3.597B 2.61
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00